药品注册申请号:076655
申请类型:ANDA (仿制药申请)
申请人:ACTAVIS LABS FL
申请人全名:ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 54MG No No AB 2018/03/21 2018/03/21 Prescription
002 METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 72MG No No AB 2022/02/28 Prescription
003 METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 36MG No No None -- None (Tentative Approval)
004 METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 54MG No No None -- None (Tentative Approval)
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2018/03/21 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:METHYLPHENIDATE HYDROCHLORIDE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:54MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021121 003 NDA CONCERTA METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 54MG Prescription Yes Yes AB 2000/12/08 JANSSEN PHARMS
206726 004 ANDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 54MG Prescription No No AB 2016/10/21 AUROLIFE PHARMA LLC
205327 004 ANDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 54MG Prescription No No AB 2017/07/28 OSMOTICA PHARM US
076655 001 ANDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 54MG Prescription No No AB 2018/03/21 ACTAVIS LABS FL
210818 004 ANDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 54MG Discontinued No No AB 2018/11/30 ALVOGEN
211918 004 ANDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 54MG Prescription No No AB 2019/04/24 ANDOR PHARMS
211009 004 ANDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 54MG Prescription No No AB 2019/09/03 ASCENT PHARMS INC
213473 004 ANDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 54MG Prescription No No AB 2020/07/29 DR REDDYS
205135 004 ANDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 54MG Prescription No No AB 2020/08/19 SUN PHARM INDS INC
214111 004 ANDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 54MG Discontinued No No AB 2022/05/31 RHODES PHARMS
214447 004 ANDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 54MG Prescription No No AB 2023/05/23 ALKEM LABS LTD
活性成分:METHYLPHENIDATE HYDROCHLORIDE 剂型/给药途径:TABLET, EXTENDED RELEASE;ORAL 规格:72MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
205327 005 ANDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 72MG Prescription No Yes AB 2017/07/28 OSMOTICA PHARM US
076655 002 ANDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 72MG Prescription No No AB 2022/02/28 ACTAVIS LABS FL
217229 001 ANDA METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 72MG Prescription No No AB 2023/08/25 SUN PHARM INDS INC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database